Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT05831709Recruiting
Randomised, open-label trial (6 arms), sponsored by Ghent University Hospital. Primary endpoints: Evaluation of the cardiovascular risk at 24 weeks and Evaluation of the insulin sensitivity at 24 weeks. Started May 2023; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT05831709.